SANOFINSESanofi India Limited· PharmaceuticalsMediumNeutral
Announced Wed, 27 May · 11:49 IST

Please find enclosed intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Regulatory & Legal View source PDF

SANOFI · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-3.9%1-day move
₹3199.40
prior close
₹3204.90
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.2+0.2+0.1+0.2-3.9-2.4-0.7+0.4-0.5-0.0+5.5+4.9+5.3
Up moveDown movePending
AI summary

Sanofi India Limited received an Order of Acceptance from the Assistant State Tax Officer, Thripunithura, Kerala, dated 25th May 2026. The tax authority had initiated scrutiny proceedings for FY 2020-21 regarding discrepancies in e-way bill generation (multiple bills, non-generation, unreported bills in GST returns) and excess input tax credit claimed. The tax amount involved was INR 59,77,141. After reviewing the company's submissions, the authority accepted them and issued an order dropping all the proceedings. The company has confirmed there is no material impact on its financial, operational or other activities.

Likely market impact

This is a positive development for Sanofi India as the tax proceedings have been fully dropped with no financial or operational impact. The matter is now closed and should not affect the stock.